<p>Hypermarcas（OTCMKTS:HYPMY - 获取免费报告）在二月份的空头头寸显著减少。截至 2 月 13 日，空头头寸总计为 16 股，较 1 月 29 日的 50,686 股减少了 100.0%。目前，该股票的空头卖出比例为 0.0%。根据平均每日交易量 90,351 股，空头头寸比率目前为 0.0 天。</p>
<h2>Hypermarcas 价格表现</h2>
<p>在周三的交易时段，HYPMY 的股价上涨了 0.10 美元，达到了 4.50 美元。该股票交易了 11,905 股，而其平均交易量为 33,058 股。公司的市值为 28.5 亿美元，市盈率为 19.57，贝塔值为 0.71。公司的流动比率为 1.27，速动比率为 0.84，债务与股本比率为 0.61。Hypermarcas 的 50 日移动平均价格为 4.48 美元，200 日移动平均价格为 4.42 美元。Hypermarcas 的 52 周最低价为 3.10 美元，52 周最高价为 5.50 美元。</p>
<h2>Hypermarcas 公司简介</h2>
<p>（获取免费报告）</p>
<p>Hypermarcas SA 是一家总部位于巴西的消费健康和制药公司，其股票在美国以 HYPMY 的符号在场外交易。该公司成立于 2000 年代初，总部位于里约热内卢，作为一个控股集团，经营着广泛的医疗保健和个人护理领域的品牌产品组合。</p>
<p>通过其各个子公司，Hypermarcas 开发、生产和销售处方药和非处方药，以及个人护理、婴儿护理、家庭护理和营养补充产品。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们认为比 Hypermarcas 更好的股票</li>
<li>华尔街害怕的黄金图表……</li>
<li>美国的 1776 年再次发生</li>
<li>这让我感到愤怒</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Hypermarcas 吗？</h2>
<p>在你考虑 Hypermarcas 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Hypermarcas 并不在名单上。</p>
<p>虽然 Hypermarcas 目前在分析师中获得了强烈买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

HYPMY

iShares拉丁美洲40指数ETF

BRAZ

<p>Hypermarcas（OTCMKTS:HYPMY）经历了空头头寸的显著下降，从 1 月 29 日的 50,686 股降至 2 月 13 日的仅 16 股，降幅达 100%。目前，该公司的空头股份仅占 0.0%，根据平均每日成交量 90,351 股，覆盖天数比率为 0.0 天。该股票交易价格为 4.50 美元，市值为 28.5 亿美元，市盈率为 19.57。Hypermarcas 是一家巴西消费健康和制药公司</p>

<p>Hypermarcas (OTCMKTS:HYPMY - Get Free Report) was the recipient of a significant decrease in short interest in February. As of February 13th, there was short interest totaling 16 shares, a decrease of 100.0% from the January 29th total of 50,686 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average daily volume of 90,351 shares, the short-interest ratio is presently 0.0 days. Based on an average daily volume of 90,351 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the shares of the stock are short sold.</p>
<div class="lb-trans"><p>Hypermarcas（OTCMKTS:HYPMY - 获取免费报告）在二月份的空头头寸显著减少。截至 2 月 13 日，空头头寸总计为 16 股，较 1 月 29 日的 50,686 股减少了 100.0%。目前，该股票的空头卖出比例为 0.0%。根据平均每日交易量 90,351 股，空头头寸比率目前为 0.0 天。</p>
</div><h2>Hypermarcas Price Performance</h2>
<div class="lb-trans"><h2>Hypermarcas 价格表现</h2>
</div><p>Shares of HYPMY traded up $0.10 during trading hours on Wednesday, reaching $4.50. 11,905 shares of the stock traded hands, compared to its average volume of 33,058. The company has a market cap of $2.85 billion, a P/E ratio of 19.57 and a beta of 0.71. The company has a current ratio of 1.27, a quick ratio of 0.84 and a debt-to-equity ratio of 0.61. The company's 50-day moving average price is $4.48 and its two-hundred day moving average price is $4.42. Hypermarcas has a 52-week low of $3.10 and a 52-week high of $5.50.</p>
<div class="lb-trans"><p>在周三的交易时段，HYPMY 的股价上涨了 0.10 美元，达到了 4.50 美元。该股票交易了 11,905 股，而其平均交易量为 33,058 股。公司的市值为 28.5 亿美元，市盈率为 19.57，贝塔值为 0.71。公司的流动比率为 1.27，速动比率为 0.84，债务与股本比率为 0.61。Hypermarcas 的 50 日移动平均价格为 4.48 美元，200 日移动平均价格为 4.42 美元。Hypermarcas 的 52 周最低价为 3.10 美元，52 周最高价为 5.50 美元。</p>
</div><h2>Hypermarcas Company Profile</h2>
<div class="lb-trans"><h2>Hypermarcas 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.</p>
<div class="lb-trans"><p>Hypermarcas SA 是一家总部位于巴西的消费健康和制药公司，其股票在美国以 HYPMY 的符号在场外交易。该公司成立于 2000 年代初，总部位于里约热内卢，作为一个控股集团，经营着广泛的医疗保健和个人护理领域的品牌产品组合。</p>
</div><p>Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.</p>
<div class="lb-trans"><p>通过其各个子公司，Hypermarcas 开发、生产和销售处方药和非处方药，以及个人护理、婴儿护理、家庭护理和营养补充产品。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Hypermarcas</li>
<li>The gold chart Wall Street is terrified of…</li>
<li>America’s 1776 happening again</li>
<li>This makes me furious</li>
<li>Buy this Gold Stock Before May 2026</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 Hypermarcas 更好的股票</li>
<li>华尔街害怕的黄金图表……</li>
<li>美国的 1776 年再次发生</li>
<li>这让我感到愤怒</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Hypermarcas Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Hypermarcas 吗？</h2>
</div><p>Before you consider Hypermarcas, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Hypermarcas 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypermarcas wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 Hypermarcas 并不在名单上。</p>
</div><p>While Hypermarcas currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Hypermarcas 目前在分析师中获得了强烈买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Hypera S.A.（OTCMKTS:HYPMY）的空头头寸下降了 100.0%